Abstract
The exon junction complex (EJC) begins to assemble on the spliceosome, which deposits EJCs upstream of most exon–exon junctions during pre-messenger RNA (mRNA) splicing. EJCs acquire additional alternative modules that define heterogeneous EJCs during pre-mRNA processing to mRNA in the nucleus and after mRNA export into the cytoplasm. In this Review, we discuss the mechanisms of EJC formation, the many roles of the EJC in pre-mRNA and mRNA regulation and how these roles are influenced by EJC composition.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout





Similar content being viewed by others
References
Wilkinson, M. E., Charenton, C. & Nagai, K. RNA splicing by the spliceosome. Annu. Rev. Biochem. 89, 359–388 (2020).
Sauliere, J. et al. CLIP–seq of eIF4AIII reveals transcriptome-wide mapping of the human exon junction complex. Nat. Struct. Mol. Biol. 19, 1124–1131 (2012). This study establishes that EJCs are deposited on approximately 60–80% of exon–exon junctions in human cells.
Schlautmann Lena, P. & Gehring Niels, H. A day in the life of the exon junction complex. Biomolecules 10, 866 (2020).
Singh, G. et al. The cellular EJC interactome reveals higher-order mRNP structure and an EJC–SR protein nexus. Cell 151, 750–764 (2012).
Hocq, R., Paternina, J., Alasseur, Q., Genovesio, A. & Le Hir, H. Monitored eCLIP: high accuracy mapping of RNA–protein interactions. Nucleic Acids Res. 46, 11553–11565 (2018).
Mishler, D. M., Christ, A. B. & Steitz, J. A. Flexibility in the site of exon junction complex deposition revealed by functional group and RNA secondary structure alterations in the splicing substrate. RNA 14, 2657–2670 (2008). This study establishes that RNA secondary structure reduces the efficiency of EJC deposition on spliced RNAs.
Cho, H. et al. AKT constitutes a signal-promoted alternative exon-junction complex that regulates nonsense-mediated mRNA decay. Mol. Cell 82, 2779–2796 (2022). This study identifies AKT as an EJC constituent that activates UPF1 in NMD and demonstrates that insulin increases the abundance of AKT-containing EJCs.
Mabin, J. W. et al. The exon junction complex undergoes a compositional switch that alters mRNP structure and nonsense-mediated mRNA decay activity. Cell Rep. 25, 2431–2446 (2018).
Wang, Z., Ballut, L., Barbosa, I. & Le Hir, H. Exon junction complexes can have distinct functional flavours to regulate specific splicing events. Sci. Rep. 8, 9509 (2018).
Choe, J. et al. eIF4AIII enhances translation of nuclear cap-binding complex-bound mRNAs by promoting disruption of secondary structures in 5′UTR. Proc. Natl Acad. Sci. USA 111, E4577–E4586 (2014).
Boehm, V. et al. Exon junction complexes suppress spurious splice sites to safeguard transcriptome integrity. Mol. Cell 72, 482–495 (2018).
Joseph, B. & Lai, E. C. The exon junction complex and intron removal prevent re-splicing of mRNA. PLoS Genet. 17, e1009563 (2021).
Blazquez, L. et al. Exon junction complex shapes the transcriptome by repressing recursive splicing. Mol. Cell 72, 496–509 (2018).
He, P. C. & He, C. mRNA accessibility within mRNPs as a determinant of gene expression. Trends Biochem. Sci. 49, 199–207 (2024).
Mokry, M., et al. Accurate SNP and mutation detection by targeted custom microarray-based genomic enrichment of short-fragment sequencing libraries. Nucleic Acids Res. 38, e116 (2010).
Zhan, X., Yan, C., Zhang, X., Lei, J. & Shi, Y. Structure of a human catalytic step I spliceosome. Science 359, 537–545 (2018).
Busetto, V. et al. Structural and functional insights into CWC27/CWC22 heterodimer linking the exon junction complex to spliceosomes. Nucleic Acids Res. 48, 5670–5683 (2020).
Alexandrov, A., Colognori, D., Shu, M. D. & Steitz, J. A. Human spliceosomal protein CWC22 plays a role in coupling splicing to exon junction complex deposition and nonsense-mediated decay. Proc. Natl Acad. Sci. USA 109, 21313–21318 (2012).
Barbosa, I. et al. Human CWC22 escorts the helicase eIF4AIII to spliceosomes and promotes exon junction complex assembly. Nat. Struct. Mol. Biol. 19, 983–990 (2012).
Ideue, T., Sasaki, Y. T., Hagiwara, M. & Hirose, T. Introns play an essential role in splicing-dependent formation of the exon junction complex. Genes Dev. 21, 1993–1998 (2007).
Chen, W. & Moore, M. J. The spliceosome: disorder and dynamics defined. Curr. Opin. Struct. Biol. 24, 141–149 (2014).
Murachelli, A. G., Ebert, J., Basquin, C., Le Hir, H. & Conti, E. The structure of the ASAP core complex reveals the existence of a Pinin-containing PSAP complex. Nat. Struct. Mol. Biol. 19, 378–386 (2012).
Meng, D. et al. A molecular brake that modulates spliceosome pausing at detained introns contributes to neurodegeneration. Protein Cell 14, 318–336 (2023).
Zhang, X. et al. Structure of the human activated spliceosome in three conformational states. Cell Res. 28, 307–322 (2018).
Boutz, P. L., Bhutkar, A. & Sharp, P. A. Detained introns are a novel, widespread class of post-transcriptionally spliced introns. Genes Dev. 29, 63–80 (2015).
Schlautmann, L. P. et al. Exon junction complex-associated multi-adapter RNPS1 nucleates splicing regulatory complexes to maintain transcriptome surveillance. Nucleic Acids Res. 50, 5899–5918 (2022). This study provides one example of how EJC constituents regulate alternative splicing and prevent cryptic splice site usage.
Wallmeroth, D. et al. Human UPF3A and UPF3B enable fault-tolerant activation of nonsense-mediated mRNA decay. EMBO J. 41, e109191 (2022).
Palma, M. et al. A role for AKT1 in nonsense-mediated mRNA decay. Nucleic Acids Res. 49, 11022–11037 (2021).
Hauer, C. et al. Exon junction complexes show a distributional bias toward alternatively spliced mRNAs and against mRNAs coding for ribosomal proteins. Cell Rep. 16, 1588–1603 (2016). This study indicates that alternative EJCs can manifest some target specificity via unknown mechanism(s).
Barutcu, A. R. et al. Systematic mapping of nuclear domain-associated transcripts reveals speckles and lamina as hubs of functionally distinct retained introns. Mol. Cell 82, 1035–1052 (2022).
Daguenet, E. et al. Perispeckles are major assembly sites for the exon junction core complex. Mol. Biol. Cell 23, 1765–1782 (2012).
Degot, S. et al. Association of the breast cancer protein MLN51 with the exon junction complex via its speckle localizer and RNA binding module. J. Biol. Chem. 279, 33702–33715 (2004).
Bensaude, O., Barbosa, I., Morillo, L., Dikstein, R. & Le Hir, H. Exon-junction complex association with stalled ribosomes and slow translation-independent disassembly. Nat. Commun. 15, 4209 (2024).
Gehring, N. H., Lamprinaki, S., Kulozik, A. E. & Hentze, M. W. Disassembly of exon junction complexes by PYM. Cell 137, 536–548 (2009).
Andersen, C. B. et al. Structure of the exon junction core complex with a trapped DEAD-box ATPase bound to RNA. Science 313, 1968–1972 (2006).
Sugimoto, Y. et al. Analysis of CLIP and iCLIP methods for nucleotide-resolution studies of protein–RNA interactions. Genome Biol. 13, R67 (2012).
Morillo, L. et al. Comprehensive mapping of exon junction complex binding sites reveals universal EJC deposition in Drosophila. BMC Biol. 21, 246 (2023).
Rodor, J., Pan, Q., Blencowe, B. J., Eyras, E. & Caceres, J. F. The RNA-binding profile of Acinus, a peripheral component of the exon junction complex, reveals its role in splicing regulation. RNA 22, 1411–1426 (2016).
Akin, D., Newman, J. R., McIntyre, L. M. & Sugrue, S. P. RNA-seq analysis of impact of PNN on gene expression and alternative splicing in corneal epithelial cells. Mol. Vis. 22, 40–60 (2016).
Long, J. C. & Caceres, J. F. The SR protein family of splicing factors: master regulators of gene expression. Biochem. J. 417, 15–27 (2009).
Blaustein, M. et al. Concerted regulation of nuclear and cytoplasmic activities of SR proteins by AKT. Nat. Struct. Mol. Biol. 12, 1037–1044 (2005).
Lee, G. & Blenis, J. Akt-ivation of RNA splicing. Mol. Cell 53, 519–520 (2014).
Zhou, Z. & Fu, X. D. Regulation of splicing by SR proteins and SR protein-specific kinases. Chromosoma 122, 191–207 (2013).
He, P. C. & He, C. m6A RNA methylation: from mechanisms to therapeutic potential. EMBO J. 40, e105977 (2021).
Ke, S. et al. A majority of m6A residues are in the last exons, allowing the potential for 3’ UTR regulation. Genes Dev. 29, 2037–2053 (2015).
Uzonyi, A. et al. Exclusion of m6A from splice-site proximal regions by the exon junction complex dictates m6A topologies and mRNA stability. Mol. Cell 83, 237–251 (2023).
He, P. C. et al. Exon architecture controls mRNA m6A suppression and gene expression. Science 379, 677–682 (2023). This study (among others, see refs. 46,48,49) determines that EJCs physically preclude m6A methylation in short internal exons.
Yang, X., Triboulet, R., Liu, Q., Sendinc, E. & Gregory, R. I. Exon junction complex shapes the m6A epitranscriptome. Nat. Commun. 13, 7904 (2022).
Luo, Z. et al. Exon–intron boundary inhibits m6A deposition, enabling m6A distribution hallmark, longer mRNA half-life and flexible protein coding. Nat. Commun. 14, 4172 (2023).
Du, H. et al. YTHDF2 destabilizes m6A-containing RNA through direct recruitment of the CCR4–NOT deadenylase complex. Nat. Commun. 7, 12626 (2016).
Hohmann, U. et al. An ATP-gated molecular switch orchestrates human messenger RNA export. Nature https://doi.org/10.1038/s41586-025-09832-z (2025).
Pacheco-Fiallos, B. et al. mRNA recognition and packaging by the human transcription-export complex. Nature 616, 828–835 (2023).
Le Hir, H., Gatfield, D., Izaurralde, E. & Moore, M. J. The exon–exon junction complex provides a binding platform for factors involved in mRNA export and nonsense-mediated mRNA decay. EMBO J. 20, 4987–4997 (2001).
Gromadzka, A. M., Steckelberg, A. L., Singh, K. K., Hofmann, K. & Gehring, N. H. A short conserved motif in ALYREF directs cap- and EJC-dependent assembly of export complexes on spliced mRNAs. Nucleic Acids Res. 44, 2348–2361 (2016).
Viphakone, N. et al. TREX exposes the RNA-binding domain of Nxf1 to enable mRNA export. Nat. Commun. 3, 1006 (2012).
Viphakone, N. et al. Co-transcriptional loading of RNA export factors shapes the human transcriptome. Mol. Cell 75, 310–323 (2019).
Chi, B. et al. A sub-element in PRE enhances nuclear export of intronless mRNAs by recruiting the TREX complex via ZC3H18. Nucleic Acids Res. 42, 7305–7318 (2014).
Wang, K. et al. Intronless mRNAs transit through nuclear speckles to gain export competence. J. Cell Biol. 217, 3912–3929 (2018).
Thomas, A. et al. RBM33 directs the nuclear export of transcripts containing GC-rich elements. Genes Dev. 36, 550–565 (2022).
Fan, J., et al. ALYREF links 3′-end processing to nuclear export of non-polyadenylated mRNAs. EMBO J. 38, e99910 (2019).
Huang, Y. & Steitz, J. A. Splicing factors SRp20 and 9G8 promote the nucleocytoplasmic export of mRNA. Mol. Cell 7, 899–905 (2001).
Ghosh, S., Marchand, V., Gaspar, I. & Ephrussi, A. Control of RNP motility and localization by a splicing-dependent structure in oskar mRNA. Nat. Struct. Mol. Biol. 19, 441–449 (2012).
Macchi, P. et al. Barentsz, a new component of the Staufen-containing ribonucleoprotein particles in mammalian cells, interacts with Staufen in an RNA-dependent manner. J. Neurosci. 23, 5778–5788 (2003).
Doyle, M. & Kiebler, M. A. Mechanisms of dendritic mRNA transport and its role in synaptic tagging. EMBO J. 30, 3540–3552 (2011).
Kwon, O. S. et al. Exon junction complex dependent mRNA localization is linked to centrosome organization during ciliogenesis. Nat. Commun. 12, 1351 (2021).
Gudikote, J. P., Imam, J. S., Garcia, R. F. & Wilkinson, M. F. RNA splicing promotes translation and RNA surveillance. Nat. Struct. Mol. Biol. 12, 801–809 (2005).
Diem, M. D., Chan, C. C., Younis, I. & Dreyfuss, G. PYM binds the cytoplasmic exon-junction complex and ribosomes to enhance translation of spliced mRNAs. Nat. Struct. Mol. Biol. 14, 1173–1179 (2007).
Chazal, P. E. et al. EJC core component MLN51 interacts with eIF3 and activates translation. Proc. Natl Acad. Sci. USA 110, 5903–5908 (2013). This study demonstrates that the alternative EJC constituent CASC3 promotes translation through a direct interaction with the eukaryotic translation initiation machinery.
Nott, A., Le Hir, H. & Moore, M. J. Splicing enhances translation in mammalian cells: an additional function of the exon junction complex. Genes Dev. 18, 210–222 (2004).
Lejeune, F., Ishigaki, Y., Li, X. & Maquat, L. E. The exon junction complex is detected on CBP80-bound but not eIF4E-bound mRNA in mammalian cells: dynamics of mRNP remodeling. EMBO J. 21, 3536–3545 (2002).
Ishigaki, Y., Li, X., Serin, G. & Maquat, L. E. Evidence for a pioneer round of mRNA translation: mRNAs subject to nonsense-mediated decay in mammalian cells are bound by CBP80 and CBP20. Cell 106, 607–617 (2001).
Maquat, L. E., Tarn, W. Y. & Isken, O. The pioneer round of translation: features and functions. Cell 142, 368–374 (2010).
Isken, O. et al. Upf1 phosphorylation triggers translational repression during nonsense-mediated mRNA decay. Cell 133, 314–327 (2008).
Hoek, T. A. et al. Single-molecule imaging uncovers rules governing nonsense-mediated mRNA decay. Mol. Cell 75, 324–339 (2019).
Chang, J. et al. An interaction between eIF4A3 and eIF3g drives the internal initiation of translation. Nucleic Acids Res. 51, 10950–10969 (2023).
Glaviano, A. et al. PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer. Mol. Cancer 22, 138 (2023).
Richardson, C. J. et al. SKAR is a specific target of S6 kinase 1 in cell growth control. Curr. Biol. 14, 1540–1549 (2004).
Ma, X. M., Yoon, S. O., Richardson, C. J., Julich, K. & Blenis, J. SKAR links pre-mRNA splicing to mTOR/S6K1-mediated enhanced translation efficiency of spliced mRNAs. Cell 133, 303–313 (2008).
Manning, B. D. & Cantley, L. C. AKT/PKB signaling: navigating downstream. Cell 129, 1261–1274 (2007).
Magnuson, B., Ekim, B. & Fingar, D. C. Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochem J. 441, 1–21 (2012).
Kurosaki, T., Popp, M. W. & Maquat, L. E. Quality and quantity control of gene expression by nonsense-mediated mRNA decay. Nat. Rev. Mol. Cell Biol. 20, 406–420 (2019).
Munoz, O., Lore, M. & Jagannathan, S. The long and short of EJC-independent nonsense-mediated RNA decay. Biochem. Soc. Trans. 51, 1121–1129 (2023).
Chamieh, H., Ballut, L., Bonneau, F. & Le Hir, H. NMD factors UPF2 and UPF3 bridge UPF1 to the exon junction complex and stimulate its RNA helicase activity. Nat. Struct. Mol. Biol. 15, 85–93 (2008).
Chakrabarti, S. et al. Molecular mechanisms for the RNA-dependent ATPase activity of Upf1 and its regulation by Upf2. Mol. Cell 41, 693–703 (2011).
Langer, L. M. et al. UPF1 helicase orchestrates mutually exclusive interactions with the SMG6 endonuclease and UPF2. Nucleic Acids Res. 52, 6036–6048 (2024).
Kashima, I. et al. SMG6 interacts with the exon junction complex via two conserved EJC-binding motifs (EBMs) required for nonsense-mediated mRNA decay. Genes Dev. 24, 2440–2450 (2010).
Gong, C., Kim, Y. K., Woeller, C. F., Tang, Y. & Maquat, L. E. SMD and NMD are competitive pathways that contribute to myogenesis: effects on PAX3 and myogenin mRNAs. Genes Dev. 23, 54–66 (2009).
Gehring, N. H. et al. Exon-junction complex components specify distinct routes of nonsense-mediated mRNA decay with differential cofactor requirements. Mol. Cell 20, 65–75 (2005). This study defines the existence of alternative EJCs comprised of different peripheral constituents in a model that continues to be developed.
Gerbracht, J. V. et al. CASC3 promotes transcriptome-wide activation of nonsense-mediated decay by the exon junction complex. Nucleic Acids Res. 48, 8626–8644 (2020).
Kunz, J. B., Neu-Yilik, G., Hentze, M. W., Kulozik, A. E. & Gehring, N. H. Functions of hUpf3a and hUpf3b in nonsense-mediated mRNA decay and translation. RNA 12, 1015–1022 (2006).
Shum, E. Y. et al. The antagonistic gene paralogs Upf3a and Upf3b govern nonsense-mediated RNA decay. Cell 165, 382–395 (2016).
Yi, Z. et al. Mammalian UPF3A and UPF3B can activate nonsense-mediated mRNA decay independently of their exon junction complex binding. EMBO J. 41, e109202 (2022).
Aznarez, I. et al. Mechanism of nonsense-mediated mRNA decay stimulation by splicing factor SRSF1. Cell Rep. 23, 2186–2198 (2018).
Sanjeev, M. et al. PYM1 limits non-canonical exon junction complex occupancy in a gene architecture dependent manner to tune mRNA expression. Nat. Commun. 16, 8138 (2025).
Ryu, I. et al. eIF4A3 phosphorylation by CDKs affects NMD during the cell cycle. Cell Rep. 26, 2126–2139 (2019).
Lin, L. et al. Epistatic interactions between NMD and TRP53 control progenitor cell maintenance and brain size. Neuron 112, 2157–2176 (2024).
Silver, D. L. et al. The exon junction complex component Magoh controls brain size by regulating neural stem cell division. Nat. Neurosci. 13, 551–558 (2010).
Lupan, B, M., Solecki, R. A., Musso, C. M., Alsina, F. C. & Silver, D. L. The exon junction complex component EIF4A3 is essential for mouse and human cortical progenitor mitosis and neurogenesis. Development 150, dev201619 (2023).
Zou, D. et al. A critical role of RBM8a in proliferation and differentiation of embryonic neural progenitors. Neural Dev. 10, 18 (2015).
Alsina, F. C. et al. The RNA-binding protein EIF4A3 promotes axon development by direct control of the cytoskeleton. Cell Rep. 43, 114666 (2024).
Favaro, F. P. et al. A noncoding expansion in EIF4A3 causes Richieri-Costa-Pereira syndrome, a craniofacial disorder associated with limb defects. Am. J. Hum. Genet. 94, 120–128 (2014).
Boussion, S. et al. TAR syndrome: clinical and molecular characterization of a cohort of 26 patients and description of novel noncoding variants of RBM8A. Hum. Mutat. 41, 1220–1225 (2020).
Weischenfeldt, J. et al. NMD is essential for hematopoietic stem and progenitor cells and for eliminating by-products of programmed DNA rearrangements. Genes Dev. 22, 1381–1396 (2008).
Mao, H., Brown, H. E. & Silver, D. L. Mouse models of Casc3 reveal developmental functions distinct from other components of the exon junction complex. RNA 23, 23–31 (2017).
Zhong, X. et al. RNPS1 inhibits excessive tumor necrosis factor/tumor necrosis factor receptor signaling to support hematopoiesis in mice. Proc. Natl Acad. Sci. USA 119, e2200128119 (2022).
Johnson, J. L. et al. Inhibition of Upf2-dependent nonsense-mediated decay leads to behavioral and neurophysiological abnormalities by activating the immune response. Neuron 104, 665–679 (2019).
Hu, J. et al. Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice. Sci. Rep. 6, 20484 (2016).
Xu, L. et al. Methylation-regulated miR-124-1 suppresses tumorigenesis in hepatocellular carcinoma by targeting CASC3. Oncotarget 7, 26027–26041 (2016).
Hers, I., Vincent, E. E. & Tavare, J. M. Akt signalling in health and disease. Cell. Signal. 23, 1515–1527 (2011).
Casamassimi, A., Federico, A., Rienzo, M., Esposito, S. & Ciccodicola, A. Transcriptome profiling in human diseases: new advances and perspectives. Int. J. Mol. Sci. 18, 1652 (2017).
Akhtar, J. et al. Promoter-proximal pausing mediated by the exon junction complex regulates splicing. Nat. Commun. 10, 521 (2019).
Acknowledgements
We thank P. Boutz and X. Rambout for comments on the manuscript. Research on EJC modularity in the Maquat laboratory is funded in part by NIH R35 GM149268 to L.E.M. and NIH K99/R00 GM152790 to E.T.A.
Author information
Authors and Affiliations
Contributions
E.T.A. and L.E.M. conceived of, wrote and modified the Review. E.T.A. generated the figures with suggestions from L.E.M.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Structural & Molecular Biology thanks Niels Gehring and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Primary Handling Editor: Sara Osman, in collaboration with the Nature Structural & Molecular Biology team.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Abshire, E.T., Maquat, L.E. Gene regulation through exon junction complex modularity. Nat Struct Mol Biol 32, 2387–2397 (2025). https://doi.org/10.1038/s41594-025-01724-0
Received:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41594-025-01724-0


